Mounjaro coming to UK

Eli Lilly has announced that it would bring the Mounjaro drug against obesity and diabetes to British patients, weeks after winning clearance for pre-filling it into an injection pen. The go-ahead from the Medicines & Healthcare products Regulatory Agency (MHRA) would make Britain the first major market to be supplied with the drug in the multi-shot pen, branded as Kwikpen. The pen will allow for convenient use and be good for a month’s treatment of one subcutaneous shot per week.

Tirzepatide is the active ingredient in Mounjaro, which will compete with Novo Nordisk’s Wegovy (semaglutide) injection drug in a booming weight-loss market.

To find out more, CLICK HERE.


Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags